Mgc Pharmaceuticals Ltd. (AU:RGT) has released an update.
Argent BioPharma Ltd. has begun trading on the OTCQB Venture Market in the United States under the ticker MGCLF, with an anticipated symbol change to enhance investor access and liquidity. The company has also appointed the experienced Igor Bluvstein as its new CFO. This move is expected to attract a broader range of investors and facilitate U.S. investment, complementing the company’s ongoing progress in drug development without affecting its ASX trading.
For further insights into AU:RGT stock, check out TipRanks’ Stock Analysis page.
